patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: PLRS investors on this board are sophisticated..latest PRs below

PLRS investors on this board are sophisticated..lates... PRs below

posted on Aug 08, 2007 07:01AM
Mon, Jul 23, 2007 • Pluristem's PLX Cells Show Promise in Treating Limb Ischemia Business Wire (Mon, Jul 23) Wed, Jul 11, 2007 • Former CEO of US Bioscience, Inc., Dr. Philip J. Schein, Joins Pluristem Business Advisory Board Business Wire (Wed, Jul 11) Mon, Jul 9, 2007 • Pluristem and Center for Regenerative Therapies at Charite University Hospital of Berlin Enters into Collaborative Research Agreement Business Wire (Mon, Jul 9)
Share
New Message
Please login to post a reply